Skip to main content
Top
Published in: International Urology and Nephrology 2/2008

01-06-2008 | Original Article

Urinary bladder leiomyosarcoma in adults

Authors: Apostolos P. Labanaris, Vahudin Zugor, Bernd Meyer, Reinhold Nützel, Stephan Helmus, Panagiotis G. Labanaris, Reinhard Kühn

Published in: International Urology and Nephrology | Issue 2/2008

Login to get access

Abstract

Introduction

Non-urothelial neoplasms of the bladder account for fewer than 5% of all bladder tumors. Sarcoma constitutes the most usual mesenchymal malignancy of the bladder, with leiomyosarcomas being the most common type of sarcoma in adults.

Patients and methods

The records of seven patients presenting to two different institutions with bladder leiomyosarcomas between 2003 and 2007 and between 2000 and 2007, respectively, were examined. Cystoscopy, with transurethral resection of the bladder tumor was initially performed in all patients, with leiomyosarcoma being initially diagnosed on the basis of examination of the transurethral specimen.

Results

There were N = 5 men and N = 2 women with a median age of 64.8 years at presentation. All seven patients underwent a definitive surgical procedure. Complete resection with negative surgical margins was achieved in all seven patients (100%). MSKCC stage included 86% of patients with stage 3 (N = 6) and 14% with stage 2 (N = 1). A low-grade tumor was evident in one patient only, with the remaining 86% exhibiting a high-grade tumor.

Discussion

Leiomyosarcomas of the bladder have always been considered as a highly aggressive entity and little is known about their origin, clinicopathologic presentation, and the survival factors associated with them. Contemporary studies suggest that these tumors may have a better prognosis than once believed. Leiomyosarcomas require aggressive surgical extirpation and, when surgical resection is possible, radical cystectomy with wide margins is the rule and should be performed. Strict adherence to standard surgical technique has resulted in low rates of positive surgical margins and low rates of local tumor recurrence.
Literature
1.
go back to reference Dahm P, Gschwend JE (2003) Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 44:672–681PubMedCrossRef Dahm P, Gschwend JE (2003) Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 44:672–681PubMedCrossRef
2.
go back to reference Berkmen F, Celebioglu AS (1997) Adult genitourinary sarcomas: a report of seventeen cases and review of the literature. J Exp Clin Cancer Res 16:45–48PubMed Berkmen F, Celebioglu AS (1997) Adult genitourinary sarcomas: a report of seventeen cases and review of the literature. J Exp Clin Cancer Res 16:45–48PubMed
3.
go back to reference Bergman RT, Kugel AI (1950) Leiomyosarcoma of the urinary bladder. Urol Cutaneous Rev. 54(2):65–67PubMed Bergman RT, Kugel AI (1950) Leiomyosarcoma of the urinary bladder. Urol Cutaneous Rev. 54(2):65–67PubMed
4.
go back to reference Sobin LH, Wittekind C (eds) (1997) International union against cancer: TNM classification of malignant tumors. Wiley–Liss, New York, pp 165–194 Sobin LH, Wittekind C (eds) (1997) International union against cancer: TNM classification of malignant tumors. Wiley–Liss, New York, pp 165–194
5.
go back to reference Hajdu SI (1979) Pathology of soft tissue tumors. Lea and Febiger, Philadelphia Hajdu SI (1979) Pathology of soft tissue tumors. Lea and Febiger, Philadelphia
6.
go back to reference Martin SA, Sears DL, Sebo TJ et al (2002) Smooth muscle neoplasms of the urinary bladder. Am J Surg Pathol 26:292–300PubMedCrossRef Martin SA, Sears DL, Sebo TJ et al (2002) Smooth muscle neoplasms of the urinary bladder. Am J Surg Pathol 26:292–300PubMedCrossRef
7.
go back to reference Morton DL, Eilber FR (1982) In: Holland JT, Fire E (eds) Soft Tissue Sarcomas. Lea and Febiger, Philadelphia, pp 21–41 Morton DL, Eilber FR (1982) In: Holland JT, Fire E (eds) Soft Tissue Sarcomas. Lea and Febiger, Philadelphia, pp 21–41
8.
go back to reference Rosenberg SA, Suit HD, Baker LH (1985) Sarcomas soft tissues. In: Devita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practices of oncology, 2nd edn. JB Lippincott, Philadelphia, pp 1243–1291 Rosenberg SA, Suit HD, Baker LH (1985) Sarcomas soft tissues. In: Devita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practices of oncology, 2nd edn. JB Lippincott, Philadelphia, pp 1243–1291
9.
go back to reference Cody HS III, Turnbull AD, Fortner JG et al (1981) The continuing challenge of retroperitoneal sarcomas. Cancer 47:2147–2153PubMedCrossRef Cody HS III, Turnbull AD, Fortner JG et al (1981) The continuing challenge of retroperitoneal sarcomas. Cancer 47:2147–2153PubMedCrossRef
10.
go back to reference Helpab B (2001) Nonepithelial neoplasms of the urinary bladder. Virchows Arch 439:497–503CrossRef Helpab B (2001) Nonepithelial neoplasms of the urinary bladder. Virchows Arch 439:497–503CrossRef
11.
go back to reference Sigal SH, Tomaszewski JE, Brooks JJ, Wein A, Li Volsi VA (1991) Carcinosarcoma of bladder following long-term cyclophosphamide therapy. Arch Pathol Lab Med 115:1049–1051PubMed Sigal SH, Tomaszewski JE, Brooks JJ, Wein A, Li Volsi VA (1991) Carcinosarcoma of bladder following long-term cyclophosphamide therapy. Arch Pathol Lab Med 115:1049–1051PubMed
12.
go back to reference Kawamura J, Sakurai M, Tsukamoto K, Tochigi H (1993) Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma. Urol Int 51:49–53PubMedCrossRef Kawamura J, Sakurai M, Tsukamoto K, Tochigi H (1993) Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma. Urol Int 51:49–53PubMedCrossRef
13.
go back to reference Pedersen-Bjergaard J, Jonsson V, Pedersen M, Hou-Jensen K (1995) Leiomyosarcoma of the urinary bladder after cyclophosphamide. J Clin Oncol 13:532–533PubMed Pedersen-Bjergaard J, Jonsson V, Pedersen M, Hou-Jensen K (1995) Leiomyosarcoma of the urinary bladder after cyclophosphamide. J Clin Oncol 13:532–533PubMed
14.
go back to reference Thrasher JB, Miller GJ, Wettlaufer JN (1990) Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol 143:119–121PubMed Thrasher JB, Miller GJ, Wettlaufer JN (1990) Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol 143:119–121PubMed
15.
go back to reference Rowland RG, Eble JN (1983) Bladder leiomyosarcoma and pelvic fibroblastic tumor following cyclophosphamide therapy. J Urol 130:344–346PubMed Rowland RG, Eble JN (1983) Bladder leiomyosarcoma and pelvic fibroblastic tumor following cyclophosphamide therapy. J Urol 130:344–346PubMed
16.
go back to reference Parekh DJ, Jung C, O’Conner J et al (2002) Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology 60:164–166PubMedCrossRef Parekh DJ, Jung C, O’Conner J et al (2002) Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology 60:164–166PubMedCrossRef
17.
go back to reference Mackenzie AR, Whitmore WF Jr, Melamed MR (1968) Myosarcomas of the bladder and prostate. Cancer 22(4):833–844PubMedCrossRef Mackenzie AR, Whitmore WF Jr, Melamed MR (1968) Myosarcomas of the bladder and prostate. Cancer 22(4):833–844PubMedCrossRef
18.
go back to reference Russo P, Brady MS, Conlon K et al (1992) Adult urological sarcoma. J Urol 147:1032–1036PubMed Russo P, Brady MS, Conlon K et al (1992) Adult urological sarcoma. J Urol 147:1032–1036PubMed
19.
go back to reference Rosser CJ, Slaton JW, Izawa JI et al (2003) Clinical presentation and outcome of high grade urinary bladder leiomyosarcoma in adults. Urology 61:1151–1155PubMedCrossRef Rosser CJ, Slaton JW, Izawa JI et al (2003) Clinical presentation and outcome of high grade urinary bladder leiomyosarcoma in adults. Urology 61:1151–1155PubMedCrossRef
20.
go back to reference Bitterman P, Chun B, Kurman RJ (1990) The significance of epithelial differentiation in mixed mesodermal tumors of the uterus: a clinicopathologic and immunohistochemical study. Am J Surg Pathol 14:317–328PubMedCrossRef Bitterman P, Chun B, Kurman RJ (1990) The significance of epithelial differentiation in mixed mesodermal tumors of the uterus: a clinicopathologic and immunohistochemical study. Am J Surg Pathol 14:317–328PubMedCrossRef
21.
go back to reference Froehner M, Lossnitzer A, Manseck A et al (2000) Favorable long-term outcome in adult genitourinary low grade sarcoma. Urology 56:373–377PubMedCrossRef Froehner M, Lossnitzer A, Manseck A et al (2000) Favorable long-term outcome in adult genitourinary low grade sarcoma. Urology 56:373–377PubMedCrossRef
22.
go back to reference McCrea LE, Post E (1955) Sarcoma of the bladder. Urol Surv 5:30 McCrea LE, Post E (1955) Sarcoma of the bladder. Urol Surv 5:30
23.
go back to reference Seo IS, Clark SA, McGovern FD, Clark DL, Johnson EH (1985) Leiomyosarcoma of the urinary bladder: 13 years after cyclophosphamide therapy for Hodgkin’s disease. Cancer 55:1597–1603PubMedCrossRef Seo IS, Clark SA, McGovern FD, Clark DL, Johnson EH (1985) Leiomyosarcoma of the urinary bladder: 13 years after cyclophosphamide therapy for Hodgkin’s disease. Cancer 55:1597–1603PubMedCrossRef
24.
go back to reference Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, Czerniak B, Kamat AM, Dinney CP, Grossman HB (2007) Review of the M.D. Anderson experience in the treatment of bladder sarcoma. Urol Oncol 25(1):38–45PubMed Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, Czerniak B, Kamat AM, Dinney CP, Grossman HB (2007) Review of the M.D. Anderson experience in the treatment of bladder sarcoma. Urol Oncol 25(1):38–45PubMed
25.
go back to reference Swartz DA, Johnson DE, Ayala AG, Watkins DL (1985) Bladder leiomyosarcoma: a review of 10 cases with 5 year follow-up. J Urol 133:200–202PubMed Swartz DA, Johnson DE, Ayala AG, Watkins DL (1985) Bladder leiomyosarcoma: a review of 10 cases with 5 year follow-up. J Urol 133:200–202PubMed
26.
go back to reference De Berardinis E, Giulianelli R, Zarrelli G, De Santis C, Ginepri A, Gentile BC et al (1997) Leiomyosarcoma of urinary bladder: personal experience in 3 cases over a 10-year period. Arch It Urol 69(Suppl 1):73–80 De Berardinis E, Giulianelli R, Zarrelli G, De Santis C, Ginepri A, Gentile BC et al (1997) Leiomyosarcoma of urinary bladder: personal experience in 3 cases over a 10-year period. Arch It Urol 69(Suppl 1):73–80
27.
go back to reference Strander H, Turesson I, Cavallin-Stahl E (2003) A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol 42:516 –31PubMedCrossRef Strander H, Turesson I, Cavallin-Stahl E (2003) A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol 42:516 –31PubMedCrossRef
28.
go back to reference O’Sullivan B, Ward I, Catton C (2003) Recent advances in radiotherapy for soft tissue sarcoma. Curr Oncol Rep 5:274–81PubMedCrossRef O’Sullivan B, Ward I, Catton C (2003) Recent advances in radiotherapy for soft tissue sarcoma. Curr Oncol Rep 5:274–81PubMedCrossRef
29.
go back to reference Harrell FE Jr, Lee KL, Matchar DB et al (1985) Regression models for prognostic prediction: Advantages, problems, and suggested solutions. Cancer Treat Rep 69:1071–1077PubMed Harrell FE Jr, Lee KL, Matchar DB et al (1985) Regression models for prognostic prediction: Advantages, problems, and suggested solutions. Cancer Treat Rep 69:1071–1077PubMed
Metadata
Title
Urinary bladder leiomyosarcoma in adults
Authors
Apostolos P. Labanaris
Vahudin Zugor
Bernd Meyer
Reinhold Nützel
Stephan Helmus
Panagiotis G. Labanaris
Reinhard Kühn
Publication date
01-06-2008
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2008
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-007-9288-5

Other articles of this Issue 2/2008

International Urology and Nephrology 2/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine